|
Enzon Pharmaceuticals inc (ENZN) |
|
Enzon Pharmaceuticals inc
ENZN's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Enzon Pharmaceuticals Inc growth rates, revenue grew
by 5.14 % in III. Quarter 2024 from the same quarter a year ago.
Ranking at No. 1690
Biotechnology & Pharmaceuticals industry recorded
growth of revenues by 13.29 %
Enzon Pharmaceuticals Inc 's net profit decreased by -20.87 % in III. Quarter 2024 year on year, to $0 millions.
• More on ENZN's Growth
|
|
Enzon Pharmaceuticals Inc current PE on trailing twelve month basis is above Biotechnology & Pharmaceuticals industry average.
Company is currently trading with Price to Cash flow multiple of 158.2 in trailing twelve-month period. Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months. |
Company |
24276.4 |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 6.12.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.44.
• More on ENZN's Valuation
|
|
|
|
|
Enzon Pharmaceuticals Inc current PE on trailing twelve month basis is above Biotechnology & Pharmaceuticals industry average.
Company is currently trading with Price to Cash flow multiple of 158.2 in trailing twelve-month period. Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months. |
Company |
24276.4 |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 6.12.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.44.
Enzon Pharmaceuticals Inc Price to Book Ratio is at 4.35 higher than Industry Avg. of -0, and higher than S&P 500 Avg. of 0.02
• More on ENZN's Valuation
|
|
Enzon Pharmaceuticals Inc net profit margin of 38.84 % is currently ranking no. 4 in Biotechnology & Pharmaceuticals industry, ranking no. 22 in Healthcare sector and number 211 in S&P 500.
• More on ENZN's Key Ratios
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com